Prognostic Factors of Treatment Outcomes in Patients with Granulocytic Sarcoma

Purpose: To investigate the possible prognostic factors of survival outcomes in patients with granulocytic sarcoma (GS). Methods: We retrospectively investigated the prognostic factors determining survival in 24 patients with GS using Kaplan-Meier survival analysis followed by log rank tests. We evaluated gender, age, location, GS antedating leukemia, underlying disorders, treatment type and stem cell transplantation. Results: The 5-year survival rate for the patients with GS was 21%. The patients undergoing chemotherapy had a significantly longer survival time compared to those who did not (p = 0.0009). We found no difference in the 5-year survival rate among the patients undergoing chemotherapy combined with radiation or surgery. Patients with chronic myelogenous leukemia and myelodysplastic disorders had worse survival rates (p = 0.0028). Conclusion: Early diagnosis with biopsy and early chemotherapy can improve survival outcome. Local radiation or surgery can improve symptoms but does not influence survival outcomes.

[1]  C. Volteau,et al.  Allogeneic hematopoietic stem-cell transplantation for myeloid sarcoma: a retrospective study from the SFGM-TC. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  J. Choi,et al.  Preceding orbital granulocytic sarcoma in an adult patient with acute myelogenous leukemia with t(8;21): a case study and review of the literature. , 2008, Cancer genetics and cytogenetics.

[3]  A. Rajan,et al.  Granulocytic sarcoma in a patient with myelodysplastic syndrome. , 2008, Oncology.

[4]  M. Frühwald,et al.  Presentation of acute promyelocytic leukemia as granulocytic sarcoma , 2008, Pediatric blood & cancer.

[5]  P. Pereira,et al.  Generalized intramuscular granulocytic sarcoma mimicking polymyositis , 2007, Skeletal Radiology.

[6]  S. Pileri,et al.  Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients , 2007, Leukemia.

[7]  G. Ruiz-Argüelles,et al.  t(8;21) (q22;q22) Acute myelogenous leukemia in México: A single institution experience , 2006, Hematology.

[8]  S. Paydaş,et al.  Granulocytic sarcoma: 32 cases and review of the literature , 2006, Leukemia & lymphoma.

[9]  L. Peterson,et al.  The 8;21 translocation in leukemogenesis , 2004, Oncogene.

[10]  E. Estey,et al.  Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy , 2003, Leukemia.

[11]  N. Tuzuner,et al.  Primary granulocytic sarcoma of the urinary bladder: case report and review of the literature. , 2002, Urology.

[12]  K. Yavuz,et al.  Granulocytic sarcoma. Cranial and breast involvement. , 2002, Clinical imaging.

[13]  K. Yamauchi,et al.  Comparison in treatments of nonleukemic granulocytic sarcoma , 2002, Cancer.

[14]  R. Stuart,et al.  Extramedullary myeloid cell tumours localised to the mediastinum: a rare clinicopathological entity with unique karyotypic features. , 2002, Journal of clinical pathology.

[15]  H. Shin,et al.  Fine‐needle aspiration biopsy of granulocytic sarcoma , 2000, Cancer.

[16]  J. Rossi,et al.  Good outcome of children with acute myeloid leukemia and t(8;21)(q22;q22), even when associated with granulocytic sarcoma , 2000, Cancer.

[17]  Harris,et al.  Extra‐medullary myeloid tumour (granulocytic sarcoma) is often misdiagnosed: a study of 26 cases , 1999, Histopathology.

[18]  J. Srigley,et al.  Granulocytic sarcoma of the female genital tract: a clinicopathologic study of 11 cases. , 1997, The American journal of surgical pathology.

[19]  C. Bloomfield,et al.  Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  D. Selby,et al.  Isolated Chloroma: The Effect of Early Antileukemic Therapy , 1995, Annals of Internal Medicine.

[21]  J. Byrd,et al.  Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: a clinical review. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  J. Langston,et al.  Granulocytic sarcoma in childhood leukemia: imaging features. , 1994, Radiology.

[23]  D. Arber,et al.  Extramedullary Myeloid Cell Tumors An Immunohistochemical and Morphologic Study of 28 Cases , 1993, The American journal of surgical pathology.

[24]  M. Tallman,et al.  Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Traweek St.  Immunophenotypic analysis of acute leukemia. , 1993 .

[26]  J. Manning,et al.  Granulocytic sarcoma in nonleukemic patients , 1986, Cancer.

[27]  J. Bennett,et al.  Granulocytic sarcoma: A clinicopathologic study of 61 biopsied cases , 1981, Cancer.

[28]  H. Muss,et al.  Chloroma and other myeloblastic tumors. , 1973, Blood.

[29]  D. Mcgregor,et al.  Autopsy study of granulocytic sarcoma (chloroma) in patients with myelogenous leukemia, hiroshima‐nagasaki 1949‐1969 , 1973, Cancer.

[30]  D. Grujičić,et al.  Spinal epidural granulocytic sarcoma in non-leukemic patient , 2009, International journal of hematology.

[31]  T. Chiou,et al.  Nonmyeloablative allogeneic bone marrow transplantation for orbital granulocytic sarcoma associated with t(8;21)(q22;q22) in acute myeloid leukemia , 2002, Bone Marrow Transplantation.

[32]  S. Kim,et al.  Spinal intramedullary granulocytic sarcoma: magnetic resonance imaging. , 1993, Magnetic resonance imaging.

[33]  S. T. Traweek.  Immunophenotypic analysis of acute leukemia. , 1993, American journal of clinical pathology.

[34]  A. List,et al.  Granulocytic sarcoma in myelodysplastic syndromes: clinical marker of disease acceleration. , 1991, The American journal of medicine.